POZ IRELAND
gpi@poz.iol.ie
HomeBasic MessageLaboratory TestsViral LoadWhen to start treatment?TreatmentsAnti-HIV DrugsDrugs and DosesSide EffectsTreatment ChangesSalvage TherapyInfectionsVaccinationsLipodystrophyMicronutritionWomen & HIVGlossary
CONTENTS
HIV & AIDS
Laboratory Tests
Full Blood Count
Lipids and Other Biochemical Values
Liver Function Tests
Viral Load
HIV Drug Resistance Tests
Genotype Testing
Keeping up with your meds
Changing Treatments
HIV treatments
INDICATIONS TO START TREATMENT
RECOMMENDED COMBINATIONS
ADVANTAGES/DISADVANTAGES OF COMBINATIONS
NUCLEOSIDE ANALOGUES (NRTI)
PROTEASE INHIBITORS (PI)
NNRTIs
ANTI-HIV DRUGS
abacavir (ziagen / abc)
AMPRENAVIR (Agenerase / APV)
COMBIVIR
DELAVIRDINE (Rescriptor / DLV)
DIDANOSINE (Videx / ddI)
EFAVIRENZ (Sustiva / EFV)
HYDROXYUREA (Hydrea)
INDINAVIR (Crixivan / IDV)
INTERLEUKIN-12 (IL-12)
INTERLEUKIN-2 (IL-2)
KALETRA
LAMIVUDINE (Epivir / 3TC)
NELFINAVIR (Viracept / NFV)
NEVIRAPINE (Viramune / NVP)
RITONAVIR (Norvir / RTV)
SAQUINAVIR (Fortovase / Invirase / SQV)
STAVUDINE (Zerit / d4T)
TENOFOVIR (TNV)
[ Home ]
